A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Excessive intravenous fluid therapy in head and neck cancer surgery




TekijätHaapio E, Kinnunen I, Airaksinen JK, Irjala H, Kiviniemi T

Julkaisuvuosi2017

JournalHead and Neck

Vuosikerta39

Numero1

Aloitussivu37

Lopetussivu41

Sivujen määrä5

ISSN1043-3074

DOIhttps://doi.org/10.1002/hed.24525

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/17943277


Tiivistelmä
BACKGROUND:

The purpose of this retrospective study was to present our assessment of modifiable perioperative factors for major cardiac and cerebrovascular events (MACCE).

METHODS:

This study included an unselected cohort of patients with head and neck cancer (n = 456) treated in Turku University Hospital between 1999 and 2008.

RESULTS:

Perioperative and postoperative univariate predictors of MACCE at 30-day follow-up were: total amount of fluids (during 24 hours) over 4000 mL, any red blood cell (RBC) infusion, treatment in the intensive care unit (ICU), tracheostomy, and microvascular reconstruction surgery. Median time from operation to MACCE was 3 days. Patients receiving >4000 mL of fluids had MACCE more often compared with those receiving <4000 mL (10.8% vs 2.4%; p < .001, respectively). Moreover, every RBC unit transfused or every liter of fluid administered over 4000 mL/24h increased the risk of MACCE 18% per unit/liter, respectively.

CONCLUSION:

Patients with head and neck cancer receiving excessive intravenous fluid administration perioperatively and postoperatively are at high risk for cardiac complications, especially heart failure. © 2016 Wiley Periodicals, Inc. Head Neck 39: 37-41, 2017.


Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 15:44